Table of Content

1. Table of Contents
1.1 List of Tables
1.2 List of Figures


2. Executive Summary
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Hospital Acquired Infection Diagnostics Market- Key Findings, 2020


3. Strategic Imperatives on Global Hospital Acquired Infection Diagnostics Market
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Hospital Acquired Infection Diagnostics Companies


4. Global Hospital Acquired Infection Diagnostics Market Value Outlook to 2026 Outlook by Product
4.1 Reagents & Consumables
4.2 Instruments


5. Global Hospital Acquired Infection Diagnostics Market Value Outlook to 2026 Outlook by Test Type
5.1 Molecular Diagnostics
5.2 Immunoassay
5.3 Urinalysis


6. Global Hospital Acquired Infection Diagnostics Market Value Outlook to 2026 Outlook by Application
6.1 Drug-resistance Testing
6.2 Disease Testing


7. Global Hospital Acquired Infection Diagnostics Market Value Outlook to 2026 Outlook by Infection Type
7.1 Urinary Tract Infections (UTIs)
7.2 Surgical Site Infections
7.3 Bloodstream Infections
7.4 Gastrointestinal Infections
7.5 Hospital Acquired Pneumonia
7.6 Others


8. Global Hospital Acquired Infection Diagnostics Market Value Outlook to 2026 Outlook by End User
8.1 Hospitals
8.2 Clinics
8.3 Ambulatory Surgery Centers (ASCs)
8.4 Others


9 Asia Pacific Hospital Acquired Infection Diagnostics Market Value Outlook to 2026
9.1 Leading Hospital Acquired Infection Diagnostics Types contributing to Asia Pacific market
9.2 Top Applications contributing to Asia Pacific Hospital Acquired Infection Diagnostics
9.3 Top countries contributing to Asia Pacific Hospital Acquired Infection Diagnostics


10 Europe Hospital Acquired Infection Diagnostics Market Value Outlook to 2026
10.1 Leading Hospital Acquired Infection Diagnostics Types contributing to Europe market
10.2 Top Applications contributing to Europe Hospital Acquired Infection Diagnostics
10.3 Top countries contributing to Europe Hospital Acquired Infection Diagnostics


11 North America Hospital Acquired Infection Diagnostics Market Value Outlook to 2026
11.1 Leading Hospital Acquired Infection Diagnostics Types contributing to North America market
11.2 Top Applications contributing to North America Hospital Acquired Infection Diagnostics
11.3 Top countries contributing to North America Hospital Acquired Infection Diagnostics


12 South and Central America Hospital Acquired Infection Diagnostics Market Value Outlook to 2026
12.1 Leading Hospital Acquired Infection Diagnostics Types contributing to South and Central America market
12.2 Top Applications contributing to South and Central America Hospital Acquired Infection Diagnostics
12.3 Top countries contributing to South and Central America Hospital Acquired Infection Diagnostics


13 Middle East Africa Hospital Acquired Infection Diagnostics Market Value Outlook to 2026
13.1 Leading Hospital Acquired Infection Diagnostics Types contributing to Middle East Africa market
13.2 Top Applications contributing to Middle East Africa Hospital Acquired Infection Diagnostics
13.3 Top countries contributing to Middle East Africa Hospital Acquired Infection Diagnostics


14 Business Profiles of Leading Companies
14.1 Business Description, SWOT and Financial Analysis of Companies in Hospital Acquired Infection Diagnostics market
14.2 Abbott Laboratories
14.3 AdvanDX
14.4 Alere Inc.
14.5 AstraZeneca plc
14.6 Bayer Schering Pharma LLC
14.7 Becton Dickinson & Company
14.8 Cepheid Inc.
14.9 Daiichi Sankyo
14.10 Danaher Corporation
14.11 Hologic, Inc.


15 Recent Industry Developments


16 Appendix
16.1 OGAnalysis Expertise
16.2 Sources and Methodology
16.3 Contacts